Some advanced protocols pair Tesamorelin with Ipamorelin or other peptides to sustain GH signaling and further support body composition, but these combinations should only be used under experienced medical supervision. Who should avoid Ipamorelin therapy
The LEADER trial (liraglutide) and SUSTAIN-6 trial (semaglutide) demonstrated cardiovascular risk reduction over multi-year follow-up periods (approximately 3.8 years and 2.1 years, respectively)
Tirzepatide, a dual GLP-1/GIP receptor agonist has been approved for glycaemic control in type 2 diabetes as well as for obesity management leading in up to 22.5% WL in phase 3 obesity trials
Research identifies over 4,000 genes influenced by this compound, affecting everything from collagen production to inflammation to wound healing
Wash hands thoroughly after handling
Experts emphasize that it depends on several factors including your expected weight loss curve, actual progress, and overall health